Response to "Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes"

Acta Diabetol. 2023 May;60(5):715-716. doi: 10.1007/s00592-023-02061-8. Epub 2023 Mar 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / etiology
  • Cardiovascular Diseases* / prevention & control
  • Diabetes Mellitus, Type 2* / chemically induced
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Feeding Behavior / drug effects
  • Glucagon-Like Peptides / therapeutic use
  • Heart Disease Risk Factors
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Risk Factors

Substances

  • semaglutide
  • Glucagon-Like Peptides
  • Hypoglycemic Agents